3.4 Views on MDTB-related issues
Likert-scale responses to 28 of 30 (93.3%) questions did not differ
between oncologist and surgeon respondents (p >0.05).
Significantly different responses were noted to 2 questions on patients
that should be discussed at MDTBs (“All new pediatric cancer patients
should be discussed in detail”, and “Patient preferences and social
circumstances should always be commented on”) (p =0.015 and
0.009, respectively). Details of responses are summarized in Fig 3 and
Supplemental Table S3.